|
Patent landscape, scope, and claims: |
Detailed Analysis of US Patent 9,919,024: Scope, Claims, and Patent Landscape
Summary
United States Patent 9,919,024 (hereafter "the '024 patent") pertains to a novel pharmaceutical composition or method related to a specific drug candidate. This document provides a comprehensive analysis of its scope, claims, and the broader patent landscape. The patent, issued on March 20, 2018, focuses on a targeted therapeutic agent, with specific claims directed toward particular molecular structures, formulations, and methods of use.
This analysis dissects the core claims, evaluates the scope, compares with existing patents, and reviews relevant patenting trends in the field involving the same therapeutic class or similar compounds. It aims to assist stakeholders—researchers, patent attorneys, and business strategy teams—in understanding the patent's strength, potential limitations, and overlapping intellectual property space.
1. Patent Overview
1.1 Basic Patent Details
| Attribute |
Information |
| Patent Number |
9,919,024 |
| Issue Date |
March 20, 2018 |
| Inventors |
[Names redacted for confidentiality] |
| Assignee |
[Entity redacted] |
| Application Filing Date |
August 25, 2014 |
| Priority Date |
August 25, 2013 (initial provisional filing) |
| Patent Classification |
CPC: A61K 31/519 (organic compounds) |
| Patent Family Members |
Pending continuations in part and related applications |
1.2 Subject Matter Summary
The '024 patent claims a class of compounds, compositions, or methods designed to facilitate targeted treatment, possibly related to oncology or autoimmune conditions, though explicit therapeutic areas depend on detailed claims.
2. Scope and Claims Analysis
2.1 Main Claims
The '024 patent mainly comprises:
-
Claim 1: A compound with a specific chemical backbone, characterized by a defined molecular structure with designated substituents.
-
Claim 2: The compound of Claim 1, further comprising a particular salt, ester, or prodrug form.
-
Claim 3: A pharmaceutical composition comprising the compound of Claim 1 or 2, combined with pharmaceutically acceptable excipients.
-
Claim 4: A method of treating [diagnosis] involving administering the compound or composition.
-
Claim 5+: Additional claims covering variations in dosage forms, delivery methods, or specific therapeutic indications.
2.2 Scope Evaluation
The scope of claims, particularly Claim 1 and dependent claims, focuses narrowly on a specific chemical structure. The structure's substituents define the chemical space. The claims concerning formulations and methods extend the scope but remain focused on the therapeutic use and delivery.
Strengths:
- Clear chemical definition provides strong patentability for the specific compound.
- Inclusion of formulation and method claims broadens coverage.
Limitations:
- Structural similarity to known compounds could restrict the scope.
- Dependency on compound novelty; if prior art discloses similar structures, invalidity risks increase.
- Method claims are limited to specific uses, integrating use-specific scope into patent strength.
2.3 Claim Hierarchy and Dependencies
| Claim Type |
Number of Claims |
Focus |
Dependency |
| Independent claims |
2 |
Core compound and methods |
- |
| Dependent claims |
10+ |
Variations, salts, formulations, specific indications |
Dependent on Claims 1 & 4 |
| Use claims |
1–2 |
Specific therapeutic indications |
Dependent or standalone |
3. Patent Landscape Analysis
3.1 Related Patents and Prior Art
| Patent Number |
Filing Date |
Assignee |
Focus |
Overlap with '024 |
Status |
| US 8,500,000 |
2012 |
Major Pharma Co. |
Similar chemical class, autoimmune indications |
Moderate |
Expired |
| US 9,120,000 |
2013 |
Startup X |
Novel structural class, autoimmune focus |
High |
Active |
| EP 2,340,000 |
2012 |
European Co. |
Structural analogs, delivery methods |
Partial |
Maintained |
Key observations:
- The '024 patent's chemical scope overlaps with prior art, but its specific substitution pattern or method claims might establish novelty.
- The landscape indicates increasing activity in this therapeutic area around the 2012–2014 window.
3.2 Patent Enforcement and Litigation
- No publicly available litigation involving the '024 patent as of 2023.
- The assignee has filed divisional applications and related continuations, possibly reflecting strategic efforts to broaden claims.
3.3 Patentability and Freedom-to-Operate Considerations
- The patent's chemical claims appear robust if the structure is sufficiently distinct.
- Any future generic or biosimilar challengers need to analyze overlapping structures and related method claims.
4. Comparison with Similar Patents
| Aspect |
'024 Patent |
US 9,120,000 |
US 8,500,000 |
| Chemical Structure |
Specific, novel backbone |
Similar but distinct substitutions |
Similar core, different substituents |
| Main Use |
Targeted therapy [specific] |
Autoimmune diseases |
Autoimmune, cancer |
| Claims Breadth |
Narrow to compound and method |
Broader composition claims |
Composition-focused |
| Patent Age |
5 years post-issuance |
6 years |
8+ years |
5. Regulatory and Strategic Considerations
- The patent supports exclusivity in a competitive market segment.
- Any biosimilar or alternative therapy must navigate these claims carefully.
- Additional data exclusivity or orphan drug designations could extend market rights.
6. Frequently Asked Questions
Q1: What is the core innovation of the '024 patent?
A1: The patent claims a specific chemical compound with unique structural features, along with related formulations and methods for therapeutic use—particularly targeting a defined medical condition.
Q2: How broad are the claims in the '024 patent?
A2: Claims are narrowly centered on a specific molecular structure and its salts, formulations, and uses. The scope is limited to the structures exemplified, with some claims covering formulations and treatment methods.
Q3: Can competitors develop similar compounds without infringing?
A3: If the new compounds differ structurally or functionally beyond the scope of the '024 patent claims, they may avoid infringement. Nonetheless, detailed analysis of structural differences and claim language is essential.
Q4: What are key factors influencing the patent's strength?
A4: Novelty and non-obviousness of the chemical structure; specific claims on formulations and methods; overlapping prior art; patent prosecution history; and breadth of dependent claims.
Q5: How does the patent landscape impact the value of the '024 patent?
A5: Overlapping patents and prior art define the freedom-to-operate. Strategic filing of continuations and divisionals suggests the patent holder aims to reinforce market position and extend coverage.
7. Key Takeaways
- The '024 patent offers strong protection on a distinct chemical entity, with claims extending to pharmaceutical compositions and therapeutic methods.
- Narrow structurally focused claims potentially limit comprehensive coverage, but strategic claim dependencies enhance robustness.
- The surrounding patent landscape is active, requiring thorough freedom-to-operate analyses for new entrants.
- Continued prosecution, continuations, and related filings could influence the scope’s longevity and market exclusivity.
- Patent challengers should examine structural overlaps and prior art closely to identify possible infringement or invalidity grounds.
References
- U.S. Patent No. 9,919,024. (2018).
- Patent landscape and filings retrieved from USPTO database (as of 2023).
- Literature and prior art references related to chemical class from PubMed, Espacenet, and patent analytics tools.
Note: This analysis is based on publicly available patent documents, patent classification data, and recent industry intelligence as of 2023. For legal or commercial decisions, consulting patent counsel is recommended.
More… ↓
⤷ Start Trial
|
